noli.

Register

Mary Claire Haver, MD@drmaryclaireTikTok

I'm a menopause doctor. My own vitamin D was low. Then I started reading my patients' …more

original sound — @drmaryclaire

what it claims

The transition to menopause naturally leads to a decrease in vitamin D and an increase in blood fats (triglycerides), independent of lifestyle. To address this, it is recommended to have your levels tested, then supplement with 4000 IU of vitamin D, vitamin K2 (to direct calcium toward the bones rather than the vessels), and 2 g of omega-3 in re-esterified (rTG) form for cardiovascular balance.

mixed

The increase in blood fats during menopause is a well-documented reality: the longitudinal observational SWAN study confirms that the hormonal transition negatively influences…

noli's read

The increase in blood fats during menopause is a well-documented reality: the longitudinal observational SWAN study confirms that the hormonal transition negatively influences this profile, independent of age or weight. To address this, the efficacy of omega-3 is solid: a meta-analysis of randomized clinical trials (RCT) from the American Heart Association shows that intakes of 2 to 4 g per day significantly reduce triglycerides. Furthermore, small clinical trials confirm that the re-esterified (rTG) form offers better absorption than cheaper forms. Regarding vitamin D, the 4000 IU dose is safe and corresponds to the daily upper limit recommended by health authorities (NIH). Conversely, the idea that vitamin K2 prevents the accumulation of calcium in blood vessels in humans relies primarily on theoretical models; current randomized clinical trials do not yet formally confirm this cardiovascular protective effect.

the sources

  1. 1NIH Office of Dietary Supplements 2026
  2. 2Manson JE et al. 2019
  3. 3NIH Office of Dietary Supplements 2026
  4. 4Bhatt DL et al. 2019

Claimed by Mary Claire Haver, MD. Noli grades the claim, never the person.

Decoded by Noli · July 14, 2026 · the original post

What the graded evidence says

Effect
CVD/cancer prevention in replete adults (VITAL) — no significant reduction
Measured on
VITAL: 25,871 adults

What’s uncertain

Great for correcting a deficiency; weak as a general preventive if you're already replete.

Mary Claire Haver, MD in the Register58 claims graded · solidity 89/100See their record →

More from Mary Claire Haver, MD

Others on this

Noli has read similar claims

Other advice in the Register that leans on the same research.

Noli, a firefly holding its lantern, at rest

Seen something like this? Send it to Noli.

Paste any health post from TikTok, Instagram, YouTube or X — or the advice itself, if someone just told you. About ten seconds, no account needed.